![Nicholas Downing](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Downing
Director/Board Member at
FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Profile
Nicholas Sinclair Downing is currently a Director at Kestra Medical Technologies, Inc., Cardurion Pharmaceuticals, Inc., and River Renal Cos.
He is an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2022.
He is also a Partner at Bain Capital Life Sciences LP since 2018.
Formerly, Dr. Downing was a Director at HeartFlow, Inc. from 2023 to 2025 and a Consultant at McKinsey & Co., Inc. Education includes a doctorate from Yale School of Medicine conferred in 2014 and an undergraduate degree from Harvard College conferred in 2007.
Nicholas Downing active positions
| Companies | Position | Start |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Director/Board Member | 2022-10-31 |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | 2019-12-31 |
Cardurion Pharmaceuticals, Inc.
 Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Director/Board Member | - |
Kestra Medical Technologies, Inc.
 Kestra Medical Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical technologies to protect and support at-risk patients | Director/Board Member | - |
River Renal Cos. | Director/Board Member | - |
Former positions of Nicholas Downing
| Companies | Position | End |
|---|---|---|
| HEARTFLOW, INC. | Director/Board Member | 2025-08-06 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Consultant / Advisor | - |
Training of Nicholas Downing
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
HeartFlow, Inc.
 HeartFlow, Inc. Packaged SoftwareTechnology Services Develops AI powered medical imaging platform that uses a patient’s coronary CT scan (CCTA) to build a personalized 3-D model of their heart and deliver a non-invasive solution for diagnosing & managing coronary artery disease | Technology Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Kestra Medical Technologies, Inc.
Kestra Medical Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical technologies to protect and support at-risk patients | Health Technology |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
River Renal Cos. |
- Stock Market
- Insiders
- Nicholas Downing
